Ciprofloxacin for the Prevention of Meningococcal Meningitis 2018
Status:
Withdrawn
Trial end date:
2019-12-31
Target enrollment:
Participant gender:
Summary
The trial is an interventional, cluster-randomized trial to assess the impact of oral
ciprofloxacin for household and community contacts of meningitis cases on the incidence of
meningitis during an epidemic.
The trial contains a nested sub-study ("resistance study") to assess the effect of a single
dose of ciprofloxacin on the prevalence of fluoroquinolone-resistant enterobacteriaceae in
the study area.